SIM
GHDX

Spark Investment Management’s Genomic Health, Inc. GHDX Stock Holding History

Spark Investment Management’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-100,500
Closed -$7.06M – 872
2018
Q3 		$7.06M Hold
100,500
– – 0.4% 55
2018
Q2 		$5.07M Sell
100,500
-900
-0.9% -$35.7K 0.3% 107
2018
Q1 		$3.17M Buy
101,400
+19,000
+23% +$630K 0.2% 160
2017
Q4 		$2.82M Sell
82,400
-53,100
-39% -$1.69M 0.15% 203
2017
Q3 		$4.35M Sell
135,500
-37,100
-21% -$1.17M 0.23% 150
2017
Q2 		$5.62M Sell
172,600
-17,100
-9% -$542K 0.35% 77
2017
Q1 		$5.97M Hold
189,700
– – 0.38% 59
2016
Q4 		$5.58M Sell
189,700
-21,900
-10% -$668K 0.46% 46
2016
Q3 		$6.12M Buy
211,600
+106,400
+101% +$2.96M 0.5% 33
2016
Q2 		$2.72M Buy
105,200
+9,099
+9% +$242K 0.25% 126
2016
Q1 		$2.38M Buy
96,101
+38,801
+68% +$1.06M 0.24% 134
2015
Q4 		$2.02M Buy
57,300
+6,200
+12% +$166K 0.26% 121
2015
Q3 		$1.08M Hold
51,100
– – 0.14% 240
2015
Q2 		$1.42M Hold
51,100
– – 0.2% 171
2015
Q1 		$1.56M Hold
51,100
– – 0.22% 146
2014
Q4 		$1.63M Buy
51,100
+26,600
+109% +$866K 0.27% 112
2014
Q3 		$693K Buy
24,500
+16,900
+222% +$471K 0.1% 277
2014
Q2 		$208K Sell
7,600
-11,700
-61% -$311K 0.03% 487
2014
Q1 		$508K Hold
19,300
– – 0.08% 356
2013
Q4 		$564K Hold
19,300
– – 0.1% 315
2013
Q3 		$588K Buy
19,300
+6,600
+52% +$221K 0.13% 218
2013
Q2 		$402K Buy
+12,700
New +$417K 0.11% 234

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Spark Investment Management's GHDX Position: Q4 2018 in Review

Spark Investment Management sold out of Genomic Health, Inc. (GHDX) in Q4 2018, closing a stake of 100,500 shares — an estimated $7.06M sold.

Spark Investment Management first reported a position in GHDX in Q2 2013 and held it in 22 quarters. The position peaked at $7.06M in Q3 2018. 228 funds tracked by Wall St. Rank hold GHDX as of Q4 2018.

  • Spark Investment Management reported no remaining Genomic Health, Inc. position as of Q4 2018 after selling out during the quarter.
  • Spark Investment Management sold 100,500 Genomic Health, Inc. shares in Q4 2018, an estimated $7.06M.
  • Spark Investment Management first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 22 quarters.
  • Spark Investment Management's Genomic Health, Inc. position peaked at $7.06M in Q3 2018.
  • 228 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2018.

Based on Spark Investment Management's 13F filing for Q4 2018, filed 12 Feb 2019.